Tag: NASDAQREGN

Business

Regeneron high-dose Eylea gains FDA approval (NASDAQ:REGN)

Iryna Drozd The US FDA has approved Regeneron Pharmaceuticals' (NASDAQ:REGN) high-dose ("HD") version of its blockbuster therapy Eylea (aflibercept). The…